Titre :
|
Midwifery care of women with sickle cell disorder (2020)
|
Auteurs :
|
Claudia Zanchin ;
Judy Bothamley
|
Type de document :
|
Article : texte imprimé
|
Dans :
|
Midirs. Midwifery Digest (Vol. 30, n° 2, June 2020)
|
Article en page(s) :
|
p. 142-149
|
Langues:
|
Anglais
|
Sujets :
|
Paramédical (MeSH)
Complications de la grossesse
;
Drépanocytose
;
Drépanocytose SC
;
Grande-Bretagne
;
Grossesse
;
Prise en charge prénatale
;
Sage-femme
;
Soins périnatals
|
Résumé :
|
Sickle cell disease (SCD) is a general name for a disorder where the person has inherited two unusual haemoglobins, one of which is sickle haemoglobin (HbS). The most prevalent and severe form of SCD is homozygous sickle cell anaemia (Hb SS). Currently, the United Kingdom has the highest incidence of SCD in Europe with approximately 150–250 births to women affected by SCD every year (Rogers et al 2019). Women with sickle cell disease will have been managing their symptoms for many years and will have a varying degree of complications related to their sickle status. Pregnancy can exacerbate some of these complications including an increased rate of painful vaso-occlusive crisis. To improve outcomes for mother and baby, care provided by a team with experience of SCD is advocated. The principal role of the midwife is to work in a collaborative partnership with the multidisciplinary team to coordinate effective women-centred care. The midwife will carry out regular assessment of the well-being of mother and baby and ensure the ‘normal’ aspects of expectant parenthood are not overlooked.
|